Moore, Chris
Bulger, Jenna
Morgan, Matt
Driscoll, Timothy
Porter, Alison
Islam, Saiful
Smyth, Mike
Perkins, Gavin
Sewell, Bernadette
Rainer, Timothy
Nanayakkara, Prabath
Okolie, Chukwudi
Allen, Susan
Fegan, Greg
Davies, Jan
Foster, Theresa
Francis, Nick
Smith, Fang Gao
Ellis, Gemma
Shanahan, Tracy
Howe, Robin
Snooks, Helen
Funding for this research was provided by:
Health and Care Research Wales (1191)
Article History
Received: 27 September 2017
Accepted: 4 March 2018
First Online: 12 March 2018
Authors’ information
: CM is the chief investigator for PhRASe. JKB is the trial manager for PhRASe. GF is the director of Swansea Trials Unit. HAS is a professor of Health Services Research and methodologist for the PhRASe. SI is the statistician for PhRASe. BS is the health economist for PhRASe. AP is the qualitative lead for PhRASe. TD is the data manager for PhRASe. GE is the lead nurse for Sepsis at University Hospital Wales. SA, PN, and TR are consultants of emergency medicine; MS is a research fellow; and MM is a consultant of Intensive Care Medicine; GP is a professor of Critical Care Medicine—all sit on the PhRASe Trial Management Group. CO is a research officer.
: The Wales Research Ethics Committee 4 granted ethical approval (reference 17-WA-0186).
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.